Medtronic (NYSE:MDT) said today it won FDA approval for a thoracotomy alternative procedure with its HVAD left ventricular assist device, which it said is a less-invasive implantation approach. The Fridley, Minn.-based medtech giant touted the approval as the first for any commercially available LVAD in the US, and said that the clearance came based on data […]